Compass Therapeutics, Inc. Annual Interest Expense in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Compass Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2018 to 2022.
  • Compass Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2022 was $0.000, a 100% decline year-over-year.
  • Compass Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2022 was $0.000, a 100% decline year-over-year.
  • Compass Therapeutics, Inc. annual Interest Expense for 2022 was $0.000, a 100% decline from 2021.
  • Compass Therapeutics, Inc. annual Interest Expense for 2021 was $370K, a 59.3% decline from 2020.
  • Compass Therapeutics, Inc. annual Interest Expense for 2020 was $908K, a 26.1% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 -$370K -100% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-15
2021 $370K -$538K -59.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $908K -$320K -26.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 $1.23M +$1.22M +37362% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-05
2018 $3.28K Apr 1, 2018 Mar 31, 2019 10-K 2020-06-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.